The reported overexpression of Gb3 in many cancers opened, a decade ago, the possibility of using the nontoxic subunit B (StxB) of the Shiga toxin coupled to different materials as contrasting agents for cancer imaging and drugs for chemotherapy and more recently for PTT [120,121,122]. The gene discussed is PPIB; the disease is cancer.